Welcome Guest | Register / Login

Pharmaceuticals Market Research Reports

Sort By
Title Published Price Buy Now
Global Radiation Therapy Market Report: 2011 Edition
By Koncept Analytics
Report SummaryRadiation Therapy refers to the medical use of ionizing radiation as a part of cancer treatment to control malignant cells by destroying their DNA. Various types of radiations are generally used for the ...
Oct 2011 $ 800
Global Diabetes Market Report: 2011 Edition
By Koncept Analytics
Report SummaryDiabetes is a group of metabolic diseases in which a person has high blood sugar which is either due to the fact that insulin produced by the body is not enough or the body does not respond to the insuli...
Oct 2011 $ 800
Cardiovascular Pharmaceuticals Market in India 2011
By Netscribes
Cardiovascular pharmaceuticals market in India is the second largest contributor to domestic pharmaceutical sales, contributing around 15.6%. Since India has a huge patient pool, the Indian market is characterized by a huge demand for cardiovascul...
Sep 2011 $ 795
Anti-Infective Pharmaceuticals Market in India 2011
By Netscribes
Anti-infective pharmaceuticals market in India is the largest contributor to domestic pharmaceutical sales, contributing around 18%. Since India has a huge patient pool, the Indian market is characterized by a huge demand for anti-infective drugs....
Sep 2011 $ 795
Global Ophthalmic Market: Focus on Diagnostics and Surgical Equipments
By Koncept Analytics
Report SummaryThe global ophthalmic market growth is driven by demographic trends, such as an increasing aged population and rising number of diabetic & ob...
Sep 2011 $ 800
Pharmaceuticals Brand PR: Developing Engaging Campaigns and Measuring ROI
By Insight Pharma Reports
The value of PR can seem immeasurable in brand positioning. Yet, in an age of budgetary juggling by marketing departments, the drive to scrutinize ROI is increasingly important. What' s more, as expectations on PR outcomes increase - in part d...
Sep 2011 $ 495
Global Osteoporosis Market & Drugs Analysis 2010 – 2015
By Renub Research
Osteoporosis Market Overview Osteoporosis is often called the "silent disease" because bone loss occurs without symptoms. It is characterized by low bone mass and micro-architectural deterioration of bone tissue, leading t...
Sep 2011 $ 950
Global Schizophrenia Prevalence, Companies Analysis & Drugs Forecast (2010 - 2015)
By Renub Research
Schizophrenia - Market Overview Schizophrenia is a mental disorder characterized by disintegration of thought processes and of emotional responsiveness. It most commonly manifests as auditory hallucinations, paranoid or bi...
Aug 2011 $ 850
Global Hepatitis C Virus (HCV) Market - An Analysis
By Koncept Analytics
Report Summary Hepatitis C virus (HCV) is commonly spread through blood from a person who has been infected through use of shared needles or equipment used to...
Aug 2011 $ 800
Kinase-Targeted Therapeutics: Development Pipelines, Challenges, and Opportunities
By Insight Pharma Reports
The field of kinase modulation is one of the most active in the biopharmaceutical industry. About 20 kinase inhibitors are approved for marketing in the United States and at least another 250 are in clinical evaluation. Kinases make up a veritable...
Aug 2011 $ 595
Pharma Marketing Excellence: Lessons From Experiences
By Insight Pharma Reports
Marketing excellence. Over the past five years, those two words have been the subject of hype and the focus of management attention. As the pharmaceutical industry struggles with market maturation and weakening product pipelines, marketing excelle...
Aug 2011 $ 595
The Impact of iPad on Pharma: A Primer
By Insight Pharma Reports
With the launch of Apple's iPad in April 2010, the way we use technology changed forever. Instant, portable and quick, the iPad is expected to sell 50 million units in 2011 alone.Its impact on Pharma is still being measured, but fo...
Jul 2011 $ 295
Alzheimer's Disease Patients & Market Worldwide, Future Scenario (2010 - 2015) & Drugs Analysis
By Renub Research
Overview Alzheimer’s is a complex disease and there is no single “magic bullet” available in the market to prevent or cure it. Though many marketed drugs have been approved for Alzheimer’s disease, ...
Jun 2011 $ 950
Brazil Diabetes Market Report & Forecast 2011-2016
By IMARC Group
Report SummaryIMARC’s new report “Brazil Diabetes Market Report & Forecast 2011-2016” provides an analytical and statistical insight into...
May 2011 $ 750
Canada Diabetes Market Report & Forecast 2011-2016
By IMARC Group
Report SummaryIMARC’s new report “Canada Diabetes Market Report & Forecast 2011-2016” provides an analytical and statistical insight into...
May 2011 $ 750
Russia Diabetes Market Report & Forecast 2011-2016
By IMARC Group
Report SummaryIMARC’s new report “Russia Diabetes Market Report & Forecast 2011-2016” provides an analytical and statistical insight into...
May 2011 $ 750
Turkey Diabetes Market Report & Forecast 2011-2016
By IMARC Group
Report SummaryIMARC’s new report “Turkey Diabetes Market Report & Forecast 2011-2016” provides an analytical and statistical insight into...
May 2011 $ 750
Italy Diabetes Market Forecast 2011-2016
By IMARC Group
Report SummaryIMARC’s new report “Italy Diabetes Market Forecast 2011-2016” provides an analytical and statistical insight into the Italian d...
Mar 2011 $ 750
France Diabetes Market Forecast 2011-2016
By IMARC Group
Report SummaryIMARC’s new report “France Diabetes Market Forecast 2011-2016” provides an analytical and statistical insight into the French d...
Mar 2011 $ 750
Biosimilars Regulatory Update: an evolving landscape
By Insight Pharma Reports
They’re costly to develop, fraught with potential patient safety concerns and subject to regulations that have yet to be written.Yet for the pharmaceutical industry, biosimilar monoclonal antibodies (mAbs) represent a potential treasu...
Feb 2011 $ 395
The 2011-2016 World Outlook for Non-Small Cell Lung Cancer Therapeutics
By ICON Group International, Inc.
This econometric study covers the world outlook for non-small cell lung cancer therapeutics across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country...
Jan 2011 $ 795
The European Pharmaceutical Directory 2011
By Asia Pacific InfoServ Pty Ltd
Report SummaryThe market potential of the European biotechnology and pharmaceutical sector is enormous and business opportunities abound. However, unraveling the maze of who’s who,...
Jan 2011 $ 376
The 2011-2016 Outlook for Non-Small Cell Lung Cancer Therapeutics in Greater China
By ICON Group International, Inc.
This econometric study covers the latent demand outlook for non-small cell lung cancer therapeutics across the regions of Greater China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipaliti...
Jan 2011 $ 495
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy